Keyphrases
Neonatal Sepsis
100%
α1-proteinase Inhibitor
100%
Sepsis
87%
Interleukin-10
37%
Systemic Cytokine
25%
Inflammatory Cytokines
12%
Neonate
12%
Aged Mice
12%
Escherichia Coli
12%
Lipopolysaccharide
12%
Beneficial Effects
12%
Protease Activity
12%
Cytokine Profile
12%
Bacterial Infection
12%
Lipopolysaccharide-induced
12%
Improved Survival
12%
Therapeutic Adjuncts
12%
Knockout Animals
12%
Systemic Response
12%
Serine Protease Inhibitor
12%
Cytokine Levels
12%
Pneumonitis
12%
Sepsis Treatment
12%
Group B Streptococcus
12%
Neonatal Mice
12%
Survival Response
12%
Significant Benefit
12%
Tissue Histology
12%
IL-10 Knockout Mice
12%
Endogenous Proteases
12%
Adult Model
12%
Pharmacology, Toxicology and Pharmaceutical Science
Inhibitor Protein
100%
Newborn Sepsis
100%
Sepsis
87%
Interleukin 10
50%
Cytokine
37%
Tumor Necrosis Factor
25%
Proteinase
12%
Bacterial Infection
12%
Escherichia Coli Lipopolysaccharide
12%
Streptococcus Agalactiae
12%
Serine Proteinase Inhibitor
12%
Lipopolysaccharide-Induced Sepsis
12%
Immunology and Microbiology
Interleukin 10
100%
Cytokine
50%
Tumor Necrosis Factor
50%
Proinflammatory Cytokine
25%
Escherichia coli
25%
Pneumonitis
25%
Streptococcus Agalactiae
25%
Serine
25%
Infection
25%